Effects of Vitamin D3 on Selected Biochemical Parameters of Nutritional Status, Inflammation, and Cardiovascular Disease in Patients Undergoing Long-term Hemodialysis
Overview
Affiliations
Introduction: Vitamin D3 has diverse biological effects extending beyond the maintenance of calcium and phosphorus homeostasis and ensuring the proper functioning of the body.
Objectives: This study evaluated the levels of vitamin D3 and its association with nutritional status, immunological activity, and selected markers of cardiovascular disease in patients on long-term hemodialysis (HD).
Patients And Methods: We measured 25-hydroxyvitamin D3 (25(OH)D3) levels in a group of 84 patients (mean age, 65 years; average time on dialysis, 32.5 months) and investigated correlations between 25(OH)D3 levels and the following parameters: albumin, body mass index, hemoglobin (Hb), interleukin 6 (IL-6), interleukin 10, C-reactive protein, asymmetric dimethylarginine (ADMA), N-terminal pro-B-type natriuretic peptide (NT-proBNP), and comorbidity score.
Results: A mean 25(OH)D3 level was 15.4 +/-7.2 ng/ml and only 5% of patients had 25(OH)D3 levels above the normal value of 30 ng/ml. There was no statistically significant difference in 25(OH)D3 levels between women and men (P = 0.06). A negative correlation was observed between 25(OH)D3 and IL-6 (R = -0.31, P = 0.009) and ADMA (R = -0.26, P = 0.03), as well as a positive correlation between 25(OH)D3 and Hb (R= 0.21, P = 0.05). There was no association between 25(OH)D3 levels and nutritional status.
Conclusions: A significant vitamin D3 deficiency observed in the majority of patients undergoing long-term HD contributes to the development of chronic inflammation, anemia, and indirectly, to endothelial cell injury.
Acute Phase Proteins and Vitamin D Seasonal Variation in End-Stage Renal Disease Patients.
Maraj M, Hetwer P, Dumnicka P, Ceranowicz P, Mazur-Laskowska M, Zabek-Adamska A J Clin Med. 2020; 9(3).
PMID: 32188088 PMC: 7141197. DOI: 10.3390/jcm9030807.
Vendramini L, Dalboni M, de Carvalho Jr J, Batista M, Nishiura J, Heilberg I Front Med (Lausanne). 2019; 6:112.
PMID: 31179282 PMC: 6542997. DOI: 10.3389/fmed.2019.00112.
Damiati S J Med Biochem. 2019; 38(2):145-152.
PMID: 30867642 PMC: 6411003. DOI: 10.2478/jomb-2018-0025.
Vitamin D and methylarginines in chronic kidney disease (CKD).
Torino C, Pizzini P, Cutrupi S, Tripepi R, Tripepi G, Mallamaci F PLoS One. 2017; 12(10):e0185449.
PMID: 28976989 PMC: 5627906. DOI: 10.1371/journal.pone.0185449.
Syed S, Michalski E, Tangpricha V, Chesdachai S, Kumar A, Prince J Inflamm Bowel Dis. 2017; 23(9):1650-1658.
PMID: 28700535 PMC: 5716347. DOI: 10.1097/MIB.0000000000001178.